Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,291 active trials259 approved drugs3,814 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,377 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00973076 | Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 1 | Jun 15, 2011 | clinicaltrials |
| NCT00960349 | Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients | completed | Phase 1 | 14 | AstraZenecaINDUSTRY | 1 | Jun 14, 2011 | clinicaltrials |
| NCT01021150 |
| Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors |
| completed |
| Phase 1 |
| 12 |
| SanofiINDUSTRY |
| 1 |
| Jun 13, 2011 |
| clinicaltrials |
| NCT00002681 | Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma | completed | Phase 1 / Phase 2 | 25 | Roger Williams Medical CenterOTHER | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00004178 | Gene Therapy in Treating Patients With Cancer | completed | Phase 1 | — | Roger Williams Medical CenterOTHER | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00504998 | Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00505271 | Safety and Efficacy Study Using Rexin-G for Breast Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00505713 | Safety and Efficacy Study Using Rexin-G for Sarcoma | completed | Phase 1 / Phase 2 | 36 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT01010880 | Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients | completed | Phase 1 / Phase 2 | 16 | Biokine Therapeutics LtdINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | completed | Phase 1 / Phase 2 | 48 | CTI BioPharmaINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00658970 | Evaluation of KX2-391 in Patients With Advanced Malignancies | completed | Phase 1 | 50 | Athenex, Inc.INDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00861107 | In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation | completed | Phase 1 / Phase 2 | 50 | Mirror Biologics, Inc.INDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00471133 | Safety and Immunogenicity of a Melanoma DNA Vaccine Delivered by Electroporation | completed | Phase 1 | 24 | Ichor Medical Systems IncorporatedINDUSTRY | 1 | Jun 7, 2011 | clinicaltrials |
| NCT00788099 | Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | 45 | PharmaMarINDUSTRY | 2 | Jun 7, 2011 | clinicaltrials |
| NCT00024557 | Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients | completed | Phase 1 | 40 | INSYS Therapeutics IncINDUSTRY | 1 | Jun 6, 2011 | clinicaltrials |
| NCT00041587 | Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma | completed | Phase 1 / Phase 2 | 80 | INSYS Therapeutics IncINDUSTRY | 3 | Jun 6, 2011 | clinicaltrials |
| NCT00064779 | Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma | completed | Phase 1 | 18 | INSYS Therapeutics IncINDUSTRY | 1 | Jun 6, 2011 | clinicaltrials |
| NCT00031278 | Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 12 | PfizerINDUSTRY | 1 | May 30, 2011 | clinicaltrials |
| NCT00405210 | Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer | completed | Phase 1 | 38 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 2 | May 23, 2011 | clinicaltrials |
| NCT00750386 | Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas | completed | Phase 1 / Phase 2 | 50 | Hellenic Oncology Research GroupOTHER | 1 | May 23, 2011 | clinicaltrials |
| NCT00752518 | A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients | completed | Phase 1 / Phase 2 | 35 | Janssen Pharmaceutical K.K.INDUSTRY | 0 | May 17, 2011 | clinicaltrials |
| NCT00840684 | Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia | completed | Phase 1 / Phase 2 | 135 | Institut Paoli-CalmettesOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00963521 | Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission | completed | Phase 1 | 10 | Institut Paoli-CalmettesOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00033228 | Vaccine Therapy in Treating Patients With Stage IV Melanoma | completed | Phase 1 / Phase 2 | 19 | Mannkind CorporationINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00559624 | Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients | completed | Phase 1 / Phase 2 | 40 | Advancell - Advanced In Vitro Cell Technologies, S.A.INDUSTRY | 3 | May 10, 2011 | clinicaltrials |
| NCT00621400 | Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis | completed | Phase 1 / Phase 2 | 27 | Nantes University HospitalOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT00193583 | Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors | completed | Phase 1 | 18 | SCRI Development Innovations, LLCOTHER | 1 | May 4, 2011 | clinicaltrials |
| NCT00437424 | A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction | completed | Phase 1 | 24 | Bristol-Myers SquibbINDUSTRY | 2 | May 4, 2011 | clinicaltrials |
| NCT00978731 | Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study | completed | Phase 1 | 46 | Bristol-Myers SquibbINDUSTRY | 0 | Apr 28, 2011 | clinicaltrials |
| NCT00005860 | Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 26, 2011 | clinicaltrials |
| NCT00028912 | Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 26, 2011 | clinicaltrials |
| NCT00055705 | PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 26, 2011 | clinicaltrials |
| NCT00700167 | Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00747734 | A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 35 | Genentech, Inc.INDUSTRY | 0 | Apr 20, 2011 | clinicaltrials |
| NCT01338948 | Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 12 | Yonsei UniversityOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00470405 | Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma | completed | Phase 1 | 25 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Apr 18, 2011 | clinicaltrials |
| NCT00103701 | BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia | completed | Phase 1 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00337454 | Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan | completed | Phase 1 / Phase 2 | 48 | Bristol-Myers SquibbINDUSTRY | 1 | Apr 14, 2011 | clinicaltrials |
| NCT00006391 | Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Apr 5, 2011 | clinicaltrials |
| NCT00010023 | Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Apr 5, 2011 | clinicaltrials |
| NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 30 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003332 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | completed | Phase 1 / Phase 2 | 36 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003548 | Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity | completed | Phase 1 | 20 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004105 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005883 | Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke | completed | Phase 1 | — | NYU Langone HealthOTHER | 0 | Mar 28, 2011 | clinicaltrials |
| NCT00006825 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Advanced Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00009997 | Trastuzumab and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer | completed | Phase 1 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00680589 | Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 28, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Jun 15, 2011source: clinicaltrials